Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
O-sialoglycoprotein endopeptidase is a bacterial neutral metalloprotease, originally isolated from Pasteurella (Mannheimia) haemolytica, that specifically hydrolyzes O-sialoglycoproteins—proteins carrying clusters of negatively charged O-linked sialic acid residues. Its most characterized activity is the selective cleavage of the peptide bond between Arg^31 and Asp in human erythrocyte glycophorin A, but it also acts on other sialylated surface glycoproteins such as CD34, CD43, CD44, CD45, IL-7 receptor, selectin receptors, and certain tumor antigens. The enzyme does not cleave non-O-glycosylated proteins or those with only N-linked sugars, and its activity is inhibited by EDTA and certain sialate analogues, reflecting its metal ion (Zn^2+ dependent, though not directly activated) requirement. The enzyme is a valuable tool in glycobiology for removing or mapping O-sialoglycan-containing domains and for selective immunomagnetic separation of stem and immune cell populations[1][3][7][10].
Cleaves peptide bonds specifically in O-sialoglycoproteins, most notably at the Arg^31-Asp bond in glycophorin A and other glycoproteins with O-linked sialic acids. Does not cleave non-O-glycosylated or N-linked glycoproteins
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on O-sialoglycoprotein endopeptidase (OSGE).